Hester Biosciences Limited (NSE: HESTERBIO), ISIN INE782E01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HESTERBIO last traded at ₹2493.65 (-1.25%), with a 52-week range of ₹1250.95 to ₹2661.65 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 53.73%, FIIs 0.31%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.